Skip to main content
Caplight Logo









Rhinostics

Rhinostics

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://rhinostics.com/

Last Round

Series A

Extension

Jun 7, 2022

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Rhinostics is a medical device company that develops and commercializes automated sample collection devices and laboratory workflow solutions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

laboratory automationsample collectionlab automationdiagnostic testinglab workflowautomated swablab roboticsrobotic decappingclinical diagnosticsmolecular diagnosticslab consumablessample accessioninghigh-throughput screeningliquid handlingbiobanking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rhinostics Comparables

Compare Rhinostics with similar companies based on industry and business-model similarity.

Rhinostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Copan Diagnostics
79%
Hamilton Company
74%
Micronic
72%

Rhinostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 7, 2022
Series A ExtensionJul 1, 2021
Series AMar 11, 2021

Rhinostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 47% MoM, reaching 1.9K.

  • Nov 12, 2025

    Monthly visitors increased 38% MoM.

Rhinostics Filings

Explore SEC and related filing metadata, where available.

Rhinostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rhinostics's valuation, stock price, and market status.

Is Rhinostics a public or private company?

Rhinostics is a private company.

What is the current stock price of Rhinostics?

Rhinostics is a private company with no public stock price. No recent secondary market data is available.

How much is Rhinostics worth (valuation)?

Valuation information for Rhinostics is not publicly available.

Can I buy Rhinostics stock?

Rhinostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rhinostics's last funding round?

Rhinostics's most recent funding round was Series A Extension on June 7, 2022.

Who are the main investors in Rhinostics?

Key investors in Rhinostics include Covid Apollo Project.

Will Rhinostics IPO soon?

No public IPO plans have been announced for Rhinostics.

How can I track Rhinostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rhinostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range4
Year Founded2020
Last FundingJun 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?